Other biological activities of the encoded protein include: binding in a membrane protein complex with Na+/H+ exchanger regulatory factor to intracellular cytoskeletal elements, playing a role in hematopoetic cell differentiation, and being expressed in vascular endothelium cells and binding to L-selectin. PCP is considered a dissociative illicit drug due to its ability to distort sight, sounds, and lead to a feeling of detachment from one’s self. Podocytes are highly differentiated epithelial cells with interdigitating foot processes covering the outer aspect of the glomerular basement membrane. Genes were engineered to make two protomers, Calmodulin Collagen-Like Protein (CCLP) and Peptide Collagen-Like Protein (PCLP), that will spontaneously self-assemble in situ due to the high Ca2+ concentration in the extracellular space and provide tunable, targeted drug delivery in a biocompatible hydrogel. The encoded protein was originally identified as an important component of glomerular podocytes. This gene encodes a member of the sialomucin protein family. Stimulate your senses & your soul with virtual drug. High PODXL protein expression was significantly associated with unfavourable clinicopathological characteristics in both cohorts.Ĭhromosome 7 - NC_000007.14 (131500262.131556617, complement) PCLP-00284-A02-P 12C60285 DD-5A-B80-P 09C61145: Additional Information by laserking : : Jacket describes the disc as 'The worlds first media trip. Underline the potential utility of PODXL as a biomarker for more precise prognostication and treatment stratification of CRC patients. Real time RT- PCR, tissue microarray, immunohistochemistry

of Sample : 270 CRC patients (cohort 1) and a prospective cohort of 337 CRC patients (cohort 2) Source : Skne University Hospital in Malm, Sweden, central district Hospital in Vsters, Sweden

Source : South-Swedish Colorectal Cancer Biobank (STABB)Īnalysis of PODXL expression in the primary tumour is sufficient for its use as a prognostic and treatment predictive biomarker in CRC, also in patients with metastatic disease.

Pclp drug